SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA, HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether the chemotherapy drug mitomycin C could help control advanced head and neck cancers that had stopped responding to all standard treatments. It involved 48 adults whose cancer had spread or returned and could not be cured by surgery or radiation. The main…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Drug trial aims to stop Cancer's return after surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab (MK-3475) to standard surgery could better control advanced head and neck cancer. It involved 67 high-risk patients with stage III or IV cancer that could be surgically removed. Researchers aimed to see if the …
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC